G Model

ARTICLE IN PRESS

JVAC-16327; No. of Pages 3

Vaccine xxx (2015) xxx–xxx

Contents lists available at ScienceDirect

Vaccine journal homepage: www.elsevier.com/locate/vaccine

Brief report

Poliovirus immunity in newly resettled adult refugees in Idaho, United States of America Clay Roscoe a,∗ , Ryan Gilles b , Alex J. Reed c , Matt Messerschmidt a , Rebecca Kinney d a

Family Medicine Residency of Idaho, Boise, ID, USA Kootenai Clinic Family Medicine Coeur d’Alene Residency, Coeur d’Alene, ID, USA Department of Family Medicine, University of Colorado School of Medicine, Denver, CO, USA d University of Washington School of Medicine, Seattle, WA, USA b c

a r t i c l e

i n f o

Article history: Received 27 November 2014 Received in revised form 6 February 2015 Accepted 30 March 2015 Available online xxx Keywords: Poliovirus vaccination Poliovirus immunity Refugee Wild poliovirus importation

a b s t r a c t Background: In the United States, vaccines have eliminated wild poliovirus (WPV) infection, though resettling refugees may lack immunity and importation of WPV remains a concern. Methods: A cross-sectional survey was performed to determine the prevalence of poliovirus immunity in adult refugees resettling in Boise, Idaho, U.S.A.; immunity was evaluated using two definitions: serotypes 1, 2 and 3 positive, or serotypes 1 and 3 positive. Results: This survey evaluated 795 adult refugees between August 2010 and November 2012. Poliovirus immunity in adults >18 years was 55.3% for serotypes 1, 2 and 3 combined, and 60% for serotypes 1 and 3 only. Conclusion: This study demonstrated a WPV immunity rate of